TREA

79368062 - ZYTONOVA

Follow

Information

  • Trademark
  • 79368062
  • Serial Number
    79368062
  • Registration Number
    7383469
  • Filing Date
    November 17, 2022
    2 years ago
  • Registration Date
    May 14, 2024
    8 months ago
  • Transaction Date
    November 30, 2024
    a month ago
  • Status Date
    May 14, 2024
    8 months ago
  • Published for Opposition Date
    February 27, 2024
    10 months ago
  • Location Date
    May 13, 2024
    8 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    MARTIN, JENNIFER
  • Attorney Docket Number
    61016.002U1
    Attorney Name
    Laurence P. Colton
    Law Office Assigned Location Code
    M70
  • Owners
Information
Mark Drawing Code
4
Mark Identification
ZYTONOVA
Case File Statements
  • GS0091: Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; analysis apparatus, namely, research laboratory analyzers, for measuring, testing and examining tissue, cells and biomolecules including dna, rna and proteins
  • GS0051: Medical preparations, namely, medical diagnostic reagents for diagnosis of genetic disorders; medical preparations for diagnostics, namely, medical diagnostic reagents for diagnosis of genetic aberrations in tumors; medical preparations for in vitro diagnostics, namely, test kits containing antibodies, probes, enzymes, buffers and reagents for diagnosis of genetic disorders including genetic aberrations in tumors; nucleic acids sequences, peptide sequences, and chemical reagents for medical and veterinary purposes; biological and chemical preparations, namely, dna, rna and oligonucleotide probes composed of biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for medical and veterinary diagnostic purposes; biological and chemical preparations for medical and veterinary purposes, namely, dna probes, rna probes and oligonucleotide probes being polynucleotides, biochemical substances, oligonucleotides, proteins and enzymes and antibodies for diagnosis of genetic disorders including genetic aberrations in tumors; diagnostic biomarker reagents for medical purposes
  • GS0351: Business management consultancy and advisory services; operation of businesses for others, namely biotechnological and medical companies; running of a holding company performed for third parties, namely business management, business administration, and providing office functions; holding company services performed for third parties, namely, development of marketing strategy, business management and business management consultation; business management and organization consultation; advisory services relating to business management; business administration; providing office functions; business development services, namely, planning and monitoring of business developments and organizational services for business purposes
  • GS0011: Chemicals for use in industry and science; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; biochemicals, namely, polynucleotides, oligonucleotides, peptides, proteins, enzymes, and antibodies for in vitro scientific and research purposes; chemicals and biochemicals, namely, nucleic acids and antibodies for use in the detection of genetic alterations, other than for medical or veterinary purposes; nucleic acids and antibodies for laboratory use; chemicals for use in industry and science, namely, dna probes, rna probes and oligonucleotide probes being biochemical substances, antibodies, enzymes, and oligonucleotides for carrying out molecular biological processes; mixtures of chemical reagents in kit form, other than for medical or veterinary purposes, namely, kits for scientific purposes consisting primarily of chemical reagents
  • GS0441: Medical services; medical diagnostic services, namely, medical testing for diagnostic or treatment purposes; in-vitro analysis for medical and pharmaceutical use, namely, medical services in the field of genetic disorders including genetic aberrations in tumors; medical services using the knowledge in the field of pathology, genetic science, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology and laboratory medicine; medical services by means of histology, cytology, immunohistology, immunohistochemistry, in situ hybridization, pcr (polymerase chain reaction), ngs (next generation sequencing), microarray hybridization (genetic chip or biochip hybridization), flow cytometry and isolation of biomolecules including DNA, RNA and proteins; medical counseling; pharmaceutical compounding services; pharmaceutical advice; medical and healthcare services relating to dna, genetics and genetic testing; medical pathology services, namely pathology diagnostic services; genetic testing for medical purposes
  • GS0101: Medical analytical apparatus for medical purposes, namely, medical diagnostic instruments for the analysis of dna, rna and proteins; automatic analyzers for medical diagnosis, namely, medical diagnostic instruments for the analysis of body fluids and tissues; genetic testing apparatus for medical purposes
  • GS0421: Science and technology services, namely, research and design in the field of genetic analyses including analyses of genetic alterations in tumors; medical laboratory services; medical research laboratory services; development of pharmaceutical preparations and medicines; clinical research, namely conducting clinical trials for others; research relating to biotechnology; scientific consultancy services relating to hazardous materials management; biological analysis, biochemical analysis, chemical analysis, scientific analysis, namely, dna, rna, and protein analysis services for scientific research purposes; scientific research in the field of genetics and genetic engineering
Case File Event Statements
  • 4/20/2023 - a year ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 4/22/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/26/2023 - a year ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 8/30/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/6/2023 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/7/2023 - a year ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 9/25/2023 - a year ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 9/25/2023 - a year ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 10/17/2023 - a year ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 11/9/2023 - a year ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/9/2023 - a year ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/10/2023 - a year ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/13/2023 - a year ago
    13 - FINAL REFUSAL WRITTEN Type: CNFR
  • 12/13/2023 - a year ago
    14 - FINAL REFUSAL E-MAILED Type: GNFR
  • 12/13/2023 - a year ago
    15 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 1/22/2024 - 11 months ago
    16 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 1/22/2024 - 11 months ago
    17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/23/2024 - 11 months ago
    18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/7/2024 - 11 months ago
    21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/27/2024 - 10 months ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/4/2024 - 10 months ago
    26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/23/2024 - 11 months ago
    19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/7/2024 - 11 months ago
    23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 2/7/2024 - 11 months ago
    20 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 2/7/2024 - 11 months ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/27/2024 - 10 months ago
    25 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 5/14/2024 - 8 months ago
    27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/14/2024 - 5 months ago
    29 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 11/8/2024 - 2 months ago
    30 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 11/9/2024 - 2 months ago
    31 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 11/30/2024 - a month ago
    32 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 5/14/2024 - 8 months ago
    28 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC